-
Curtis HH. The immunizing cure of hay fever. Med News. 1900;77:16.
-
Noon L. Prophylactic inoculation against hay fever. Lancet. 1911;1:1572–1573.
-
McEwen LM. Ganderton MA. Wilson CW. Black JH. Hyaluronidase in the treatment of allergy. Br Med J. 1967;2:507–508.
-
McEwen LM, Starr MS. Enzyme potentiated hyposensitization I: The effect of pre-treatment with betaglucuronidase hyaluronidase and antigen on anaphylactic sensitivity of guinea pigs, rats and mice. Int Arch Allergy. 1972;42:152–158.
-
McEwen LM. Enzyme potentiated hyposensitization II: Effect of glucose, glucosamine, N-acetylaminosugars and gelatin on the ability of beta-glucuronidase to block the anamnestic response to antigen in mice. Ann Allergy. 1973;31:79–83.
-
McEwen LM, Nicholson M, Kitchen I, White S. Enzyme potentiated hyposensitization III: Control by sugars and diols of the immunological effect of beta-glucuronidase in mice and patients with hay fever. Ann Allergy. 1973;31(11):543–550.
Advertisement -
McEwen LM, Nicholson M, Kitchen I, O’Gorman J. Enzyme potentiated hyposensitization IV: effect of Protamine on the immunological behavior of beta-glucuronidase in mice and patients with hay fever. Ann Allergy. 1975;34:290–295.
-
McEwen LM. Enzyme potentiated hyposensitization V: Five case reports of patients with acute food allergy. Ann Allergy. 1975;35:98–103.
-
McEwen LM. A double-blind controlled trial of enzyme potentiated hyposensitization for the treatment of ulcerative colitis. Clin Ecol. 1987;5(2):47–51.
-
Santa Fe Center for Allergy & Environmental Medicine [website]. www.drshrader.com Accessed July 1, 2014.
-
Shrader WA. Physician Manual for LDA. Ultra Low Dose Allergen Immunotherapy. November 2008. Available through Dr. Shrader’s office.
-
Dr. William Shrader offers lectures on LDA at the American Academy of Environmental Medicine (aaemonline.org), and Dr. John Wyckoff at the Pan American Allergy Society (paas.org).
-
Shrader Jr. WA, McEwen LM. Enzyme potentiated desensitization: A sixteen month trial of therapy with 134 patients. Environ Med. 1993;9(3–4):128–38.
-
Shrader WA. Treating allergies with EPD immunotherapy. In: Nichols TW, Faass N. Optimal Digestion. Harper-Collins; 1999:370–378.
-
Saporta D. Efficacy of sublingual immunotherapy versus subcutaneous injection immunotherapy in allergic patients. J Environ Public Health. 2012;2012. Article ID 492405. doi:10.1155/2012/492405.
-
Saporta D. Changes in peak flow meter values during immunotherapy administration. J Environ Public Health. 2012. Article ID 212867.
-
Davis WE, Cook PR, McKinsey JP and Templer JP. Anaphylaxis in immunotherapy. Otolaryngol Head Neck Surg. 1992;107(1):78–83.
-
Cook PR, Bryant JL, Davis WE, et al. Systemic reactions to immunotherapy: the American Academy of Otolaryngic Allergy morbidity and mortality survey. Otolaryngol Head Neck Surg. 1994;110(6):487–493.
-
Saporta D. Reactions to sub-lingual immunotherapy: an analysis of a group of patients who developed adverse events over a period of 5 years. Does glycerin play a role? Townsend Lett. Epub August/September 2014.
Authors
-
View all postsDavis W. Lamson, MS, ND, received a naturopathic doctor degree from Bastyr University in 1982, and has been a staff physician at Tahoma Clinic. His original training was as a research chemist; and prior to practicing at Tahoma Clinic, he held positions in teaching and/or research at Iowa State University, Drexel University, and the University of Pennsylvania School of Medicine. He believes this initial training to be a major benefit in locating underlying causes of medical problems for his patients.
-
-
-
-
-
-
-
-
-











0 Comments